益生菌改善了小鼠过敏诱导喘的指标:通过元分析进行系统性审查
Ricardo Augusto Silva1, Maria Julia Brolezzi Nahas1, Sophia de Castro Bremer2
1Food, Nutrition and Basic, Experimental and Clinical Health Research Group, Department of Functional Sciences, Faculty of Medicine, Western São Paulo University (UNOESTE), São Paulo, Brazil.
Journal of the science of food and agriculture
|May 10, 2025
概括
在过敏性喘的临床前模型中,益生菌补充剂显著降低了炎症细胞和关键介质蛋白. 这些发现支持进一步进行喘预防和治疗的临床试验.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 微生物组科学 微生物组科学
背景情况:
- 全球过敏性喘患病率正在上升,需要新的治疗策略.
- 目前对过敏性喘的治疗需要补充或替代方法.
- 肠道微生物组和益生菌在调节免疫反应中的作用是一个正在积极研究的领域.
研究的目的:
- 系统地审查和元分析益生菌对过敏喘参数的影响.
- 在由卵素 (OVA),家尘 (HDM) 和OVA+脂聚糖 (LPS) 诱导的临床前模型中评估益生菌的疗效.
主要方法:
- 对8项涉及182只动物的研究进行了系统审查和元分析.
- 数据来源于七个主要的科学数据库 (PubMed,ScienceDirect,科学网,Scielo,Scopus,EMBASE,谷歌学者) 的数据.
- 使用PRISMA指南和Rayyan软件选择的研究,采用特定的关键字和医学主题标题.
主要成果:
- 总和差异性炎症细胞数量的显著减少 (乙酸性细胞,淋巴细胞,巨细胞,中性细胞) (P < 0.05).
- 肺组织度的显著下降 介质素-13 (IL-13) 和介质素-33 (IL-33).
- 益生菌补充剂在动物模型中显示对关键喘指标有缓解作用.
结论:
- 在临床前模型中,益生菌补充剂有效降低了与过敏喘相关的炎症标志物.
- 这些发现为在人类中进行随机临床试验提供了强有力的理由.
- 进一步的研究可以探索用于预防和治疗过敏性喘的益生菌.
相关概念视频
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112


